Emerging therapeutic strategies in myocardial preservation: Focus on ATP-sensitive K channels

Expert Opinion on Therapeutic Targets

Volumn 2, Issue 2, 1998, Pages 181-193

  Jovanovic, Aleksandar ^a   Jovanovic, Sofija ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006778014     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2.2.181     Document Type: Article

References (109)

1. KUSUOKA H, PORTERFIELD JK, WEISMAN ML, MARBAN E: Pathophysiology and pathogenesis of stunned myocardium: depressed Ca2+ activation of contraction as a consequence of reperfusion injury induced cellular calcium overload in ferret hearts. J. Clin. Invest. (1987) 79:950-961. (Pubitemid 17050924)
2. PEPPER JR, KHAGANI A, YACOUB M: Heart transplantation. J. Antimicrob. Chemother. (1995) 36(Suppl. B):23-38.
3. SOUTHARD JH, BELZER FO: Organ preservation. Ann. Rev. Med. (1995) 46:235-247.
4. STRINGHAM JC, SOUTHARD JH, ANDERSON GM, BELZER FO: Mechanism of ATP depletion in the cold-stored heart. Transplant. Proc. (1991) 23:2437-2438.
5. BIGELOW WG, LINDSAY WK, GREENWOOD WF: Hypothermia its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann. Surg. (1950) 132:849-866.
6. SHUMWAY NE, LOWER RR: Topical cardiac hypothermia for extended periods of anoxic arrest. Surg. Forum (1959) 10:563-566.
7. SONNENBLICK EH, ROSS J, Jr., BRAUNWALD E: Oxygen consumption of the heart. Newer concepts of its multifactorial determination. Am. J. Cardiol. (1968) 22:328-336.
8. BUCKBERG GD, BRAZIER JR, NELSON RL et al.: Studies of the effects of hypothermia on regional blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart. J. Thorac. Cardiovasc. Surg. (1977) 73:87-94. (Pubitemid 8055548)
9. CLEVELAND JC, MELDRUM DR, ROWLAND RT, BANERJEE A, HARKEN AH: Optimal myocardial preservation: cooling, cardioplegia and conditioning. Ann. Thorac. Surg. (1996) 61:760-768. (Pubitemid 26060924)
10. ROE BB, HUTCHINSON JC, FISHMAN NH, ULLYOT DJ, SMITH DL: Myocardial protection with cold, ischemic, potassium-induced cardioplegia. J. Thorac. Cardiovasc. Surg. (1977) 73:366-374. (Pubitemid 8056440)
11. CONTI VR, BERTRANOU EG, BLACKSTONE EH, KIRKLIN JW, DIGERNEES SB: Cold cardioplegia versus hypothermia for myocardial protection. J. Thoracic. Cardiovasc. Surg. (1978) 76:577-589. (Pubitemid 9061866)
12. FLAHERTY JT, WEISFELDT ML, HOLLIS DP et al.: Mass spectrometry and phosphorus-31 nuclear magnetic resonance demonstrate additive myocardial protection by potassium cardioplegia and hypothermia during global ischemia. Adv. Myocardiol. (1980) 2:487-499.
13. MENASCHE P: New strategies in myocardial preservation. Curr. Opin. Cardiol. (1997) 12:504-514. (Pubitemid 27501161)
14. GHARAGOZLOOF,BULKLEYBH,HUTCHINSGMet al.: Potassium-induced cardioplegia during normothermic cardiac arrest. Morphologic study of the effect of various concentrations of potassium on myocardial anoxic injury. J. Thorac. Cardiovasc. Surg. (1979) 77:602-607.
15. GOMEZ LA, ALEKSEEV AE, ALEKSANDROVA LA, BRADY PA, TERZIC A: Use of the MTTassay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. J. Mol. Cell. Cardiol. (1997) 29:1255-1266. (Pubitemid 27211906)
16. JOVANOVIC A, LOPEZ JR, TERZIC A: Cytosolic Ca2+ domain-dependent protective action of adenosine in cardiomyocytes. Eur. J. Pharmacol. (1996) 298:63-69.
17. JOVANOVIC A, ALEKSEEV AE, LOPEZ JR, SHEN WK, TERZIC A: Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann. Thorac. Surg. (1997) 63:153-161. (Pubitemid 27039053)
18. JOVANOVIC A, LOPEZ JR, ALEKSEEV AE, SHEN WK, TERZIC A: Adenosine prevents K+-induced Ca2+ loading: novel insight into cardiac protection during hyperkalemic cardioplegia. Ann. Thorac. Surg. (1998) 65:586-591.
19. LICHESTEIN SV, ASHE KA, EL DALATI H et al.: Warm heart surgery. J. Thorac. Cardiovasc. Surg. (1991) 101:269-274.
20. ROZENKRANZ ER, VINTEN-JOHANSEN J, BUCKBERG GD et al.: Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts, with maintenance. J. Thorac. Cardiovasc. Surg. (1982) 84:667-677.
21. TEOH KH, CHRISTAKIS GT, WEISEL RD et al.: Accelerated myocardial metabolic recovery with terminal warm cardioplegia. J. Thorac. Cardiovasc. Surg. (1986) 91:888-895. (Pubitemid 16092991)
22. MARTINTD,CRAVERJM,GOTTJP et al.: Prospective, randomized trial of retrogradewarm cardioplegia: myocardial benefit and neurologic threat. Ann. Thorac. Surg. (1994) 57:298-304. (Pubitemid 24101123)
23. NAYLOR CD, LICHESTEIN SV, FREMES SE: Warm heart investigators. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet (1994) 343:559-563. (Pubitemid 24066374)
24. TANI M: Mechanism of Ca2+-overload in reperfused ischemic myocardium. Ann. Rev. Physiol. (1990) 52:543-559. (Pubitemid 20103554)
25. GRANGER DN, KORTHIUS RJ: Physiologic mechanisms of postischemic tissue injury. Ann. Rev. Physiol. (1995) 57:311-332.
26. CHAMBERS DJ, BRAIMBRIDGE MV, HEARSE DJ: Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann. Thorac. Surg. (1987) 44:291-297. (Pubitemid 18020607)
27. EMERIT I, FABIANI JN: 1988: Clastogenic factor in ischemia-reperfusion injury during open-heart surgery: protective effect of allopurinol. Updated in 1995. Ann. Thorac. Surg. (1995) 60:736-737.
28. MYERS CL, WEISS SJ, KIRSH MM, SHEPERD BM, SHLAFER M: Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts. J. Thorac. Cardiovasc. Surg. (1986) 91:281-289. (Pubitemid 16164441)
29. MENASCHE P, GROUSSET C, GAUDUEL Y, MOUAS C, PIWNICA A: Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Circulation (1987) 76(Suppl. 5):180-185. (Pubitemid 17162537)
30. DROSSOS G, LAZOU A, PANAGOPOULOS P, WESTABY S: Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann. Thorac. Surg. (1995) 59:169-172.
31. MORITA K, IHNKEN K, BUCKBERG GH et al.: Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J. Clin. Invest. (1994) 93:2658-2666. (Pubitemid 24177184)
32. WILKIE DR: Generation of protons by metabolic processes other than glycolysis in muscle cells: a critical view. J. Mol. Cell. Cardiol. (1979) 11:325-330.
33. GEVERS W: Generation of protons by metabolic processes in heart cells. J. Mol. Cell. Cardiol. (1977) 9:867-874. (Pubitemid 8231854)
34. ROVETTO MJ, LAMBERTON WF, NEELY JR: Mechanisms of glycolytic inhibition in ischemic rat hearts. Circ. Res. (1975) 37:742-751.
35. FRY CH, POOLE-WILSON PA: Effects of acid base changes on excitation-contraction coupling in guinea-pig and rabbit cardiac ventricular muscle. J. Physiol. (1981) 313:141-160. (Pubitemid 11125566)
36. TAKACH TJ, GLASSMAN LR, RIBAKOVE GH, CLARK RE: Continuous measurement of intramyocardial pH: correlation to functional recovery following normothermic and hypothermic global ischemia. Ann. Thorac. Surg. (1986) 42:31-36. (Pubitemid 16088458)
37. ORCHARD CH, KENTISH JC: Effects of changes of pH on the contractile function of cardiac muscle. Am. J. Physiol. (1990) 258:C967-C981. (Pubitemid 20210344)
38. TERZIC A, PUCEAT M, CLEMENT O, SCAMPS F, VASSORT G: Alpha 1-adrenergic effects on intracellular pH and calcium and on myofilaments in single rat cardiac cells. J. Physiol. (1992) 447:275-292.
39. TAIT GA,BOOKERPD,WILSONGJ et al.: Effect of multidose cardioplegia and cardioplegic solution buffering on myocardial tissue acidosis. J. Thorac. Cardiovasc. Surg. (1982) 83:824-829. (Pubitemid 13097347)
40. BARNER HB: Blood cardioplegia: a review and comparision with crystalloid cardioplegia. Ann. Thorac. Surg. (1991) 52:1354-1367.
41. NEETHLING WML, VAN DEN HEEVER JJ, COOPER S, MEYER JM: Interstitial pH during myocardial preservation: assessment of five methods of myocardial preservation. Ann. Thorac. Surg. (1993) 55:420-426. (Pubitemid 23060816)
42. FRELIN C, VIGNE P, LADOUX A, LAZDUNSKI M: The regulation of the intracellular pH in cells from vertebrates. Eur. J. Biochem. (1988) 174:3-14.
43. RUSS U, BALSER C,SCHOLZWet al.: Effects of theNa+/H+-exchange inhibitorHOE642 on intracellular pH, calcium and sodium in isolated rat ventricular myocytes. Pflugers Arch. (Eur. J. Physiol.) (1996) 433:26-34. (Pubitemid 26405617)
44. MYERS ML, KARMAZYN M: Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694. Ann. Thorac. Surg. (1996) 61:1400-1406. (Pubitemid 26150227)
45. LOHM,KLONERRA,BRAUNWALDE: Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. Am. J. Cardiol. (1985) 56:672-677. (Pubitemid 16203696)
46. LOPEZ JR, GHANBARI RA, TERZIC A: A KATP channel opener protects cardiomyocytes fromCa2+ waves: a laser confocal microscopy study. Am. J. Physiol. (1996) 270:H1384-H1389.
47. LOPEZ JR,JAHANGIR R,JAHANGIR A,SHEN WK,TERZIC A: Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J. Thorac. Cardiovasc. Surg. (1996) 112:820-831. (Pubitemid 26347040)
48. JOVANOVIC A, JOVANOVIC S, LORENZ E, TERZIC A: Recombinant cardiac ATP-sensitive K+ channel subunits confer resistance towards chemical hypoxia-re-oxygenation injury. Circulation (1998) 98:1548-1555. (Pubitemid 28481672)
49. BROWN PS, Jr., HOLLAND FW, PARENTEAU GL, CLARK RE: Magnesium ion is beneficial in hypothermic crystalloid cardioplegia. Ann. Thorac. Surg. (1991) 51:359-367.
50. CASPI J, RUDIS E, BAR I, SAFADI T, SAUTE M: Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann. Thorac. Surg. (1995) 59:942-947.
51. JOVANOVIC A, LOPEZ JR, ALEKSEEV AE, SHEN WK, TERZIC A: Adenosine and K+-induced Ca2+ loading. Ann. Thorac. Surg. (1997) 64:588-589.
52. DE JONG JW, DER MEER PV, LOON HV, OWEN P, OPIE LH: Adenosine as an adjunct to potassium cardioplegia: effect on function, energy metabolism, and electrophysiology. J. Thorac. Cardiovasc. Surg. (1990) 100:445-454. (Pubitemid 20282096)
53. TOOMBS CF, MCGEE DS, JOHNSTON WE, VINTEN-JOHANSEN J: Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation (1992) 86:986-994.
54. HUDSPETH DA, NAKANASHI K, VINTEN-JOHANSEN J et al.: Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann. Thorac. Surg. (1994) 58:1637-1644. (Pubitemid 24378970)
55. MULLAN EK: The prototype adenosine regulating agent for reducing myocardial ischemic injury. Cardiovasc. Res. (1993) 27:43-47.
56. MANGANO DT: For the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Effects of acadesine on myocardial infarction, stroke and death following surgery. A meta-analysis of the 5 international randomized trials. JAMA (1996) 277:325-332. (Pubitemid 27045014)
57. BUCKBERG GD: Invited editorial on "effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest". J. Thorac. Cardiovasc. Surg. (1996) 112:1661-1663.
58. REED MK, BARAK C, MALLOY CR, MANISCALCO SP, JESSEN ME: Effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest. J. Thorac. Cardiovasc. Surg. (1996) 112:1651-1660.
59. VANHANEN I, HAKANSON E, JORFELDT L, SVEDJEHOLM R: Intravenous aspartate infusion after a coronary operation: effects on myocardial metabolism and hemodynamic state. Ann. Thorac. Surg. (1998) 65:1296-1302. (Pubitemid 28241684)
60. BEYERSDORF F, KIRISH M, BUCKBERG GD, ALLEN BS: Warm glutamate/aspartate- enriched blood cardioplegic solution for perioperative sudden death. J. Thorac. Cardiovasc. Surg. (1992) 104:1141-1147.
61. ABD-ELFATTAH AS, JESSEN ME, WECHSLER AS: Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning" in absence of adenosine. Possible separation between ischemic and reperfusion injury. J. Thorac. Cardiovasc. Surg. (1994) 108:269-278. (Pubitemid 24258666)
62. BLEESE N, DORING V, KALMAR P et al.: Intraoperative myocardial protection by cardioplegia in hypothermia. Clinical findings. J. Thorac. Cardiovasc. Surg. (1978) 75:405-413. (Pubitemid 8296656)
63. NOMA A: ATP-regulated K+ channels in cardiac muscle. Nature (1983) 305:147-148.
64. GROSS GJ: ATP-sensitive potassium channels and myocardial preconditioning. Basic Res. Cardiol. (1995) 90:85-88.
65. HEARSE DJ: Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection. Cardiovasc. Res. (1995) 30:1-17.
66. TERZIC A, JAHANGIR A, KURACHI Y: Cardiac ATP-sensitive K+ channels regulation by intracellular nucleotides and K+ channel opening drugs. Am. J. Physiol. (1995) 269:C525-C545.
67. GROVER GJ: Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can. J. Physiol. Pharmacol. (1997) 75:309-315. (Pubitemid 27304436)
68. SCHWARZ ER, WHYTE WS, KLONER RA: Ischemic preconditioning. Curr. Opin. Cardiol. (1997) 12:475-481. (Pubitemid 27417512)
69. JOVANOVIC A, ALEKSEEV AE, TERZIC A: Intracellular diadenosine polyphosphates: a novel family of inhibitory ligands of the ATP-sensitive K+ channel. Biochem. Pharmacol. (1997) 54:219-225. (Pubitemid 27356997)
70. GARLID KD, PAUCEK P, YAROV-YAROVOY V et al.: Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Circ. Res. (1997) 81:1072-1082.
71. HOLMUHAMEDOV E, JOVANOVIC S, DZEJA PP, JOVANOVIC A, TERZIC A: Mitochondrial ATP-sensitiveK+ channels modulate cardiac mitochondrial function. Am. J. Physiol. (1998) 275(Heart Circ. Physiol. 44):H1567-H1576.
72. COHEN NM, WISE RM, WECHSLER AS, DAMIANO RJ: Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. J. Thorac. Cardiovasc. Surg. (1993) 106:17-28.
73. LIGHT PE, SABIR AA, ALLEN BG, WALSH MP, FRENCH RJ: Protein kinase C-induced changes in the stoichiometry ofATPbinding activate cardiac ATP-sensitiveK+ channels.A possible mechanistic link to ischemic preconditioning. Circ. Res. (1996) 79:399-406. (Pubitemid 26276900)
74. JOVANOVIC A, JOVANOVIC S, CARRASCO AJ, TERZIC A: Acquired resistance of a mammalian cell line to hypoxia-re-oxygenation through co-transfection of Kir6.2 and SUR1 clones. Lab. Invest. (1998) 78:1101-1107. (Pubitemid 28440826)
75. JAYAWANT M, STEPHENSON ER, DAMIANO RJ: Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas' hospital solution during prolonged ischemia. J. Thorac. Cardiovasc. Surg. (1998) 116:131-138. (Pubitemid 28328637)
76. ESCANDE D, THURINGER D, LEGUERN SL et al.: Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes. Pfluger's Arch. (Eur. J. Physiol.) (1989) 414:669-675. (Pubitemid 19236290)
77. LAWTON JS, HSIA PW, ALLEN CT, DAMIANO RJ: Myocardial protection in the acutely injured heart: hyperpolarizing versus depolarizing hypothermic cardioplegia. J. Thorac. Cardiovasc. Surg. (1997) 113:567-575. (Pubitemid 27149141)
78. JENKINS DP, STEARE SE, YELLON DM: Preconditioning the human myocardium-recent advances and aspirations for the development of a new means of cardioprotection in clinical practice. Cardiovasc. Drugs Ther. (1995) 9:739-747. (Pubitemid 26058943)
79. PERRAULT LP, MENASCHE P: Role of preconditioning in cardiac surgery. Basic Res. Cardiol. (1997) 92(Suppl. 2):54-56. (Pubitemid 28019820)
80. PRZYKLENK K, KLONER RA: Ischemic preconditioning-exploring the paradox. Prog. Cardiovasc. Dis. (1998) 40:517-547.
81. YELLON DM, ALKHULAFI AM, PUGSLEY WB: Preconditioning the human myocardium. Lancet (1993) 342:276-277. (Pubitemid 23224422)
82. IKONOMIDIS JS, TUMIATI LC, WEISEL RD, MICKLE DAG, LI R-K: Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia. Cardiovasc. Res. (1994) 28:1285-1291. (Pubitemid 24264740)
83. WALKER DM, WALKER JM, PUGSLEY WB, PATTISON CW, YELLON DM: Preconditioning in isolated superfused human muscle. J. Mol. Cell. Cardiol. (1995) 27:1349-1357.
84. CLEVELAND JC, Jr., MELDRUM DR, ROWLAND RT, BANARJEE A, HARKEN AH: Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel. J. Mol. Cell. Cardiol. (1997) 29:175-182. (Pubitemid 27129141)
85. TOMAI F, CREA F, GASPARDONE A et al.: Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation (1994) 90:700-705. (Pubitemid 24242735)
86. CLEVELAND JC, MELDRUM DR, CAIN BS, BANARJEE A, HARKEN AH: Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation (1997) 96:29-32. (Pubitemid 27298399)
87. CLEVELAND JC, MELDRUM DR, ROWLAND RT, BANARJEE A, HARKEN AH: Preconditioning and hypothermic cardioplegia protect human heart equally against ischemia. Ann. Thorac. Surg. (1997) 63:147-152. (Pubitemid 27039051)
88. BRADY PA, TERZIC A: The sulfonylurea controversy-more questions from the heart. J. Am. Coll. Cardiol. (1998) 31:950-956.
89. WILLIAMS RS, THOMAS JA, FINA M, GERMAN Z, BENJAMIN IJ: Human heat shock protein 70 (hsp70) protects murine cells from injury during metabolic stress. J. Clin. Invest. (1993) 92:503-508. (Pubitemid 23209035)
90. TROST SU,OMENS JH,KARLON WJ et al.: Protection against myocardial dysfunction after a brief ischemic preconditioning in transgenic mice expressing inducible heat shock protein 70. J. Clin. Invest. (1998) 101:855-862. (Pubitemid 28096083)
91. ROBINSON BL, MORITA T, TOFT DO, MORRIS JJ: Accelerated recovery of postischemic stunned myocardium after induced expression of myocardial heat-shock protein (HSP70). J. Thorac. Cardiovasc. Surg. (1995) 109:753-764.
92. AMRANI M, CORBETT J, BOATENG SY, DUNN MJ, YACOUB MH: Kinetics of induction and protective effect of heart-shock proteins after cardioplegic arrest. Ann. Thorac. Surg. (1996) 61:1407-1412. (Pubitemid 126335746)
93. TAGGART DP, BAKKENIST CJ, BIDDOLPH SC, GRAHAM AK, MCGEE JO: Induction of myocardial heat shock protein 70 during cardiac surgery. J. Pathol. (1997) 182:362-366. (Pubitemid 27285791)
94. SUGDEN PH, BOGOYEVITCH MA: Intracellular signalling through protein kinases in the heart. Cardiovasc. Res. (1995) 30:478-492.
95. BROOKS G, HEARSE DJ: Role of protein kinase C in ischemic preconditioning: player or spectator? Circ. Res. (1996) 79:627-630. (Pubitemid 26276923)
96. TERZIC A, TUNG RT, INANOBE A, KATADA T, KURACHI Y: G-proteins activate ATP-sensitive K+ channels by antagonizing ATP-dependent gating. Neuron (1994) 12:885-893.
97. SATO T, O'ROURKE B, MARBAN E: Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ. Res. (1998) 83:110-114. (Pubitemid 28322105)
98. LEE HT, LAFARO RJ, REED GE: Pretreatment of human myocardium with adenosine during open heart surgery. J. Cardiovasc. Surg. (1995) 10:665-676.
99. COX MH, SEUN-JUN O, HEBBAR L et al.: Protective effects of adenosine on myocyte contractility during cardioplegic arrest. Ann. Thorac. Surg. (1997) 63:981-987. (Pubitemid 27194997)
100. MELDRUM DR, CLEVELAND JC, SHERIDAN BC et al.: Cardiac preconditionning with calcium: clinically accessible myocardial protection. J. Thorac. Cardiovasc. Surg. (1996) 112:778-786. (Pubitemid 26347035)
101. COPE JT, MAUNEY MC, BANKS D et al.: Intravenous phenylephrine preconditioning of cardiac grafts form non-heart-beating donors. Ann. Thorac. Surg. (1997) 63:1664-1668. (Pubitemid 27321531)
102. PIGNAT J, BOURGOUIN J, DUMONT L: Cold cardioplegia and the K+ channel modulator aprikalim (RP 52891): improved cardioprotection in isolated ischemic rabbit hearts. Can. J. Physiol. Pharmacol. (1994) 72:126-132. (Pubitemid 24156226)
103. GROVER GJ, D'ALONZO AJ, HESS T, SLEPH PG, DARBENZIO RB: Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc. Res. (1995) 30:731-738.
104. LIU YG, SATO T, O'ROURKE B, MARBAN E: Mitochondrial ATP-dependent potassium channels-novel effectors of cardioprotection. Circulation (1998) 97:2463-2469. (Pubitemid 28278191)
105. QUAS TU:DotheK+ channel openers relax smooth muscle by openingK+ channels. Trends Pharmacol. Sci. (1993) 14:332-337.
106. EDWARDS G, WESTON AH: Pharmacology of the potassium channel openers. Cardiovasc. Drugs Ther. (1995) 9(Suppl. 2):185-193.
107. INAGAKI N, GONOI T, CLEMENT JP et al.: A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitiveK+ channels. Neuron (1996) 16:1011-1017. (Pubitemid 26171205)
108. INAGAKI N, GONOI T, CLEMENT JP et al.: Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science (1995) 270:1166-1170.
109. ISOMOTO S, KONDO C, YAMADAMet al.: A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J. Biol. Chem. (1996) 271:24321-24324. (Pubitemid 26333158)